Chalice Mining at Mining Forum Americas 2026: gonnville push

Chalice Mining is targeting a first investment decision for its Gonneville critical-minerals project in H1 2028, supported by a December 2025 PFS showing a 23-year mine life, AUD 1.4 billion pre-tax NPV, 23% IRR and sub-three-year payback. The company holds AUD 59 million of cash and no debt, trades at roughly 0.3x NAV with a AUD 500 million market capitalization, and expects export credit agencies to provide 60%-70% of development funding. The principal near-term risk is permitting, with environmental documents due by year-end and a ministerial decision expected in H1 2028; Gonneville also has substantial palladium leverage, with each AUD 100/oz price increase adding about AUD 250 million to NPV.

Analysis

CHN’s apparent NAV discount is not directly monetizable: the project valuation is pre-tax and pre-financing, while the equity must still absorb feasibility spend, permitting slippage, construction execution and whatever equity-like return strategic capital demands. Export-credit debt can reduce dilution, but it raises completion and covenant risk; AUD 59m is not a credible buffer against a multi-year approval process plus bankable-study and pilot-program costs if funding markets tighten. The relevant valuation benchmark is therefore funded, post-tax NAV discounted for a 2028 investment decision—not the headline PFS NAV.

The near-term underwriting hinge is metallurgical reproducibility, not the promotional palladium narrative. A small pilot is useful but cannot fully de-risk recoveries, concentrate specifications, impurity penalties or ramp-up performance at commercial scale; any weak result would likely re-open the stock’s historical processing discount within days. Over 1-3 months, pilot results and exploration assays can drive liquidity-led upside, while 6-18 month value depends on environmental-document acceptance, credible offtake terms and evidence that ECAs will finance on acceptable leverage. Palladium upside is asymmetric but the asserted AI/data-center demand should be treated as unverified until end-user procurement emerges; autocatalyst demand remains vulnerable to faster BEV penetration, substitution toward platinum, and Russian supply normalization.

Key Decisions for Investors

• Keep CHN (ASX) on a catalyst watch rather than establish a full position before pilot results; initiate only after saleable-concentrate assays confirm recoveries and payable-metal terms. Size as a 6-18 month special situation, with a 50% maximum initial tranche given binary metallurgy and permitting risk.
• For a commodity-led expression, prefer a small long CHN / short PALL pair after successful pilot results: CHN offers project-specific rerating optionality while PALL hedges part of the palladium-price exposure. Exit the pair if palladium falls materially while CHN fails to outperform, signaling the market is re-pricing funding or process risk rather than metal beta.
• Set event alerts for environmental submission acceptance, feasibility capex guidance, offtake announcements and ECA term-sheet disclosure. Do not underwrite the no-equity-financing claim until management identifies total development capex, debt-service coverage assumptions, required sponsor equity and streaming/offtake economics.
• Treat a delay to the targeted approval timetable, lower-than-expected pilot recovery/concentrate quality, or a feasibility capital-cost increase of more than 15% as thesis-falsification triggers; these would compress the probability-weighted NAV enough to overwhelm a modest palladium rally.